e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
argenx SE - American Depositary Shares
(NQ:
ARGX
)
993.12
+141.84 (+16.66%)
Streaming Delayed Price
Updated: 3:06 PM EDT, Aug 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
511,972
Open
927.33
Bid (Size)
992.50 (40)
Ask (Size)
993.93 (160)
Prev. Close
851.29
Today's Range
925.62 - 1,002.16
52wk Range
650.01 - 953.58
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
There are notable gap-ups and gap-downs in today's session.
↗
Today 10:30 EDT
Via
Chartmill
argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing
↗
Today 10:03 EDT
argenx (NASDAQ:ARGX) reported positive top-line results from its Phase III ALKIVIA trial of VYVGART Hytrulo in autoimmune myositis, meeting its primary endpoint in a combined population of patients...
Via
MarketBeat
Topics
Intellectual Property
Performance
YTD
+18.2%
+18.2%
1 Month
+15.4%
+15.4%
3 Month
+27.9%
+27.9%
6 Month
+17.7%
+17.7%
1 Year
+50.2%
+50.2%
More News
Read More
$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today
↗
Today 10:00 EDT
Via
Benzinga
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
Today 1:00 EDT
From
argenx SE
Via
GlobeNewswire
Here’s How Much You Would Have Made Owning argenx Stock In The Last 5 Years
↗
August 10, 2026
Via
Benzinga
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
August 06, 2026
From
argenx SE
Via
GlobeNewswire
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
August 03, 2026
From
argenx SE
Via
GlobeNewswire
argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102
↗
July 27, 2026
Via
MarketBeat
Topics
Intellectual Property
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline
July 27, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
July 27, 2026
From
argenx SE
Via
GlobeNewswire
argenex Q2 Earnings Call Highlights
↗
July 23, 2026
Via
MarketBeat
Topics
Earnings
Intellectual Property
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
July 23, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026
July 16, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Host Autoimmune Myositis R&D Webinar
June 23, 2026
From
argenx SE
Via
GlobeNewswire
argenx Eyes More VYVGART Growth as Pipeline Catalysts Near
↗
June 12, 2026
Via
MarketBeat
Topics
Intellectual Property
Supply Chain
argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference
↗
June 05, 2026
Via
MarketBeat
Topics
Intellectual Property
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
June 03, 2026
From
argenx SE
Via
GlobeNewswire
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%
↗
May 29, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More
↗
May 29, 2026
Via
The Motley Fool
argenx to Host Myositis R&D Webinar on June 23, 2026
May 28, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Present at Upcoming Investor Conferences
May 27, 2026
From
argenx SE
Via
GlobeNewswire
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
↗
May 16, 2026
Via
The Motley Fool
2 Ways to Play the Big Pharma Patent Cliff
↗
May 15, 2026
Via
MarketBeat
Topics
ETFs
Intellectual Property
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
May 08, 2026
From
argenx SE
Via
GlobeNewswire
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
May 07, 2026
From
argenx SE
Via
GlobeNewswire
Frequently Asked Questions
Is argenx SE - American Depositary Shares publicly traded?
Yes, argenx SE - American Depositary Shares is publicly traded.
What exchange does argenx SE - American Depositary Shares trade on?
argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for argenx SE - American Depositary Shares?
The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
What is the current price of argenx SE - American Depositary Shares?
The current price of argenx SE - American Depositary Shares is 993.12
When was argenx SE - American Depositary Shares last traded?
The last trade of argenx SE - American Depositary Shares was at 08/17/26 03:06 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.